China Device Reforms Aplenty: Multiple Regulatory Changes Are Imminent
This article was originally published in The Gray Sheet
Executive Summary
New rules relating to unannounced inspections, expanded good manufacturing practice requirements and revised product classification rules will each kick in the next four to five months, while new requirements pertaining to the submission of clinical trial records recently took effect.